Pyrazinamide
PYRAZINAMIDE TABLETS USP, 500 mg
Approved
Approval ID
ecee3128-a47f-4ced-a1db-4f58c5f3e9c6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 14, 2022
Manufacturers
FDA
Akorn
DUNS: 117693100
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Pyrazinamide
PRODUCT DETAILS
NDC Product Code61748-012
Application NumberANDA081319
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 14, 2022
Generic NamePyrazinamide
INGREDIENTS (6)
PYRAZINAMIDEActive
Quantity: 500 mg in 1 1
Code: 2KNI5N06TI
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT